Cardiac troponin T lysine 210 deletion in a family with dilated cardiomyopathy.

Abstract:

BACKGROUND:The gene for cardiac troponin T (TNNT2) is 1 of 7 autosomal disease genes implicated in familial dilated cardiomyopathy (FDC). Identical deletions in exon 13 of TNNT2 have been reported in 2 families with FDC, but little is known about the frequency of this deletion among patients with FDC and idiopathic dilated cardiomyopathy (IDC) and the associated phenotype. METHODS AND RESULTS:Exon 13 of the cardiac troponin T gene was sequenced in 61 subjects with FDC and 53 subjects with IDC. A 3-base pair deletion (DeltaLys210), identified in 1 family with at least 7 clinically affected family members, is reported. Age of disease onset and disease severity varied widely among affected individuals; phenotypic findings included dilated cardiomyopathy, sudden cardiac death, conduction system disease including atrial fibrillation and atrioventricular block, and heart failure. Sudden-onset, rapidly progressive disease was observed in younger individuals. CONCLUSIONS:Cardiac troponin T exon 13 lysine deletions can cause FDC of varying severity and are an important but uncommon cause of FDC.

journal_name

J Card Fail

authors

Hanson EL,Jakobs PM,Keegan H,Coates K,Bousman S,Dienel NH,Litt M,Hershberger RE

doi

10.1054/jcaf.2002.31157

keywords:

subject

Has Abstract

pub_date

2002-02-01 00:00:00

pages

28-32

issue

1

eissn

1071-9164

issn

1532-8414

pii

S1071916402155102

journal_volume

8

pub_type

杂志文章
  • Doxercalciferol, a pro-hormone of vitamin D, prevents the development of cardiac hypertrophy in rats.

    abstract:BACKGROUND:Activated vitamin D analog, paricalcitol, has been shown to attenuate the development of cardiac hypertrophy in Dahl salt sensitive (DSS) rats. To determine whether an antihypertrophic effect is class specific, we tested if doxercalciferol (a pro-hormone vitamin D2 analog) could also attenuate the developmen...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2011.08.006

    authors: Choi JH,Ke Q,Bae S,Lee JY,Kim YJ,Kim UK,Arbeeny C,Thadhani R,Kang PM

    更新日期:2011-12-01 00:00:00

  • The force-interval relationship of the left ventricle: a quantitative description in patients with ischemic heart disease.

    abstract::Quantitative descriptions of the mechanical restitution curve as a description of variability in ventricular performance with coupling interval in isolated tissue preparations are widely available. In humans, however, in vivo examination of the force-interval relationship is restricted to test pulse intervals shorter ...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/1071-9164(95)90002-0

    authors: Ritchie RH,Wuttke RD,Hii JT,Jarrett RG,Carey AL,Horowitz JD

    更新日期:1995-09-01 00:00:00

  • Effects of short-term forearm exercise training on resistance vessel endothelial function in normal subjects and patients with heart failure.

    abstract:BACKGROUND:Exercise training improves endothelium-dependent vasodilation in animals. This study was designed to determine whether forearm exercise training improves endothelium-dependent vasodilation in control subjects and patients with heart failure, a disease associated with abnormal endothelium-dependent vasodilati...

    journal_title:Journal of cardiac failure

    pub_type: 临床试验,杂志文章

    doi:10.1016/s1071-9164(98)80006-7

    authors: Bank AJ,Shammas RA,Mullen K,Chuang PP

    更新日期:1998-09-01 00:00:00

  • Cardiovascular Magnetic Resonance May Avoid Unnecessary Coronary Angiography in Patients With Unexplained Left Ventricular Systolic Dysfunction: A Retrospective Diagnostic Pilot Study.

    abstract:BACKGROUND:Coronary angiography (CA) is usually performed in patients with reduced left ventricular ejection fraction (LVEF) to search ischemic cardiomyopathy. Our aim was to examine the agreement between CA and cardiovascular magnetic resonance (CMR) imaging among a cohort of patients with unexplained reduced LVEF, an...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2020.09.005

    authors: Desroche LM,Milleron O,Safar B,Ou P,Garbarz E,Lavie-Badie Y,Abtan J,Millischer D,Pathak A,Durand-Zaleski I,Cattan S,Ronchard T,Jondeau G

    更新日期:2020-12-01 00:00:00

  • Aldosterone antagonism improves endothelial-dependent vasorelaxation in heart failure via upregulation of endothelial nitric oxide synthase production.

    abstract:BACKGROUND:Altering the renin-angiotensin aldosterone system improve mortality in heart failure (HF) in part through an improvement in nitric oxide (NO)-mediated endothelial function. This study examined if spironolactone affects endothelial nitric oxide synthase (eNOS) and NO-mediated vasorelaxation in HF. METHODS AN...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2006.01.002

    authors: Thai HM,Do BQ,Tran TD,Gaballa MA,Goldman S

    更新日期:2006-04-01 00:00:00

  • Outcomes of volume-overloaded cardiovascular patients treated with ultrafiltration.

    abstract:BACKGROUND:Ultrafiltration (UF) can rapidly and predictably remove extracellular and intravascular fluid volume. To date, assessment of UF in patients with cardiovascular disease has been confined to short- and medium-term studies in patients with a principal diagnosis of acute heart failure. METHODS:In-hospital and l...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2008.02.003

    authors: Jaski BE,Romeo A,Ortiz B,Hoagland PM,Stone M,Glaser D,Thomas L,Walsh C,Smith SC Jr

    更新日期:2008-08-01 00:00:00

  • Association of Serum Zinc Level With Prognosis in Patients With Heart Failure.

    abstract:BACKGROUND:Zinc is an essential cofactor for energy transfer and physiological heart function, has antioxidant properties, and is involved in multiple signaling pathways. We aimed to investigate the associations between serum zinc levels with prognosis, as well as underlying cardiac function and exercise capacity, in p...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2018.02.011

    authors: Yoshihisa A,Abe S,Kiko T,Kimishima Y,Sato Y,Watanabe S,Kanno Y,Miyata-Tatsumi M,Misaka T,Sato T,Suzuki S,Oikawa M,Kobayashi A,Yamaki T,Kunii H,Nakazato K,Ishida T,Takeishi Y

    更新日期:2018-06-01 00:00:00

  • Effects of Angiotensin-Neprilysin Inhibition in Canines with Experimentally Induced Cardiorenal Syndrome.

    abstract:BACKGROUND:Sacubitril/valsartan (Sac/Val), a combined angiotensin-II receptor blocker (Val) and neprilysin inhibitor (Sac) in a 1:1 molar ratio, was shown to decrease the risk of cardiovascular death or heart failure (HF) hospitalization in patients with HF and reduced left ventricular (LV) ejection fraction. This stud...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2020.08.009

    authors: Sabbah HN,Zhang K,Gupta RC,Xu J,Singh-Gupta V

    更新日期:2020-11-01 00:00:00

  • Left ventricular assist device support and myocardial recovery in recent onset cardiomyopathy.

    abstract:BACKGROUND:Left ventricular assist device (LVAD) support as bridge to recovery (BTR) is uncommon for subjects with chronic heart failure. Myocardial recovery is more evident in recent onset nonischemic cardiomyopathy (ROCM); however, the prevalence of BTR in this subset has not been addressed. METHODS AND RESULTS:We e...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2012.08.001

    authors: Boehmer JP,Starling RC,Cooper LT,Torre-Amione G,Wittstein I,Dec GW,Markham DW,Zucker MJ,Gorcsan J 3rd,McTiernan C,Kip K,McNamara DM,IMAC Investigators.

    更新日期:2012-10-01 00:00:00

  • Rationale and design of the enoximone clinical trials program.

    abstract:BACKGROUND:Chronic heart failure is a disease syndrome characterized in its advanced stages by a poor quality of life, frequent hospitalizations, and a high risk of mortality. In advanced and ultra-advanced chronic heart failure, many treatment options, such as cardiac transplantation and mechanical devices, are severe...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2005.10.013

    authors: Lowes BD,Shakar SF,Metra M,Feldman AM,Eichhorn E,Freytag JW,Gerber MJ,Liard JF,Hartman C,Gorczynski R,Evans G,Linseman JV,Stewart J,Robertson AD,Roecker EB,Demets DL,Bristow MR

    更新日期:2005-12-01 00:00:00

  • Intravenous salt supplementation with low-dose furosemide for treatment of acute decompensated heart failure.

    abstract:BACKGROUND:Theoretically, salt supplementation should promote diuresis through increasing the glomerular filtration rate (GFR) during treatment of acute decompensated heart failure (ADHF) even with low-dose furosemide; however, there is little evidence to support this idea. METHODS AND RESULTS:This was a prospective, ...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.cardfail.2014.01.012

    authors: Okuhara Y,Hirotani S,Naito Y,Nakabo A,Iwasaku T,Eguchi A,Morisawa D,Ando T,Sawada H,Manabe E,Masuyama T

    更新日期:2014-05-01 00:00:00

  • HFSA 2006 Comprehensive Heart Failure Practice Guideline.

    abstract::Heart failure (HF) is a syndrome characterized by high mortality, frequent hospitalization, reduced quality of life, and a complex therapeutic regimen. Knowledge about HF is accumulating so rapidly that individual clinicians may be unable to readily and adequately synthesize new information into effective strategies o...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章,实务指引

    doi:10.1016/j.cardfail.2005.11.005

    authors: Heart Failure Society Of America

    更新日期:2006-02-01 00:00:00

  • Reasons Why Eligible Candidates Decline Left Ventricular Assist Device Placement.

    abstract:BACKGROUND:A greater understanding of how beliefs and perceptions inform LVAD placement refusals can help ensure that standards for informed decision making are met. We report on the factors that influence refusal and what accounts for changes in decliners' decision-making process when, and if, that occurs. METHOD AND...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2015.06.008

    authors: Bruce CR,Kostick KM,Delgado ED,Wilhelms LA,Volk RJ,Smith ML,McCurdy SA,Loebe M,Estep JD,Blumenthal-Barby JS

    更新日期:2015-10-01 00:00:00

  • Design of an acute dP/dt hemodynamic measurement protocol to isolate cardiac effect of pacing.

    abstract:BACKGROUND:Invasively measured maximum increase in left ventricular pressure (LV dP/dtmax) has been used to assess biventricular (BiV) pacing. We quantified extracardiac factors contributing to its variability, and developed a protocol to minimize these effects in an acute pacing experiment. METHODS AND RESULTS:Contin...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2014.01.020

    authors: Thibault B,Dubuc M,Karst E,Andrade J,Dyrda K,Guerra PG,Macle L,Rivard L,Roy D,Talajic M,Ryu K,Farazi TG,Varma N,Khairy P

    更新日期:2014-05-01 00:00:00

  • Elevated Heart Rate Following Heart Transplantation Is Associated With Increased Graft Vasculopathy and Mortality.

    abstract:BACKGROUND:The effect of elevated heart rate (HR) on outcomes after heart transplantation (HT) has not been well established. The aim of this study was to assess predictors of elevated HR following HT and its impact on outcomes. METHODS AND RESULTS:We retrospectively evaluated 394 patients who underwent HT at 2 academ...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章,多中心研究

    doi:10.1016/j.cardfail.2019.01.009

    authors: Liebo M,Newman J,Joshi A,Lowes BD,Peled-Potashnik Y,Basha HI,Zolty R,Um JY,McGee E Jr,Heroux A,Raichlin E

    更新日期:2019-04-01 00:00:00

  • Symptoms characteristic of heart failure among CKD patients without diagnosed heart failure.

    abstract:BACKGROUND:Epidemiological studies typically diagnose heart failure (HF) at the time of hospitalization, and have not evaluated the prevalence of HF symptoms in CKD patients without a prior HF diagnosis. METHODS AND RESULTS:We modified the Kansas City Cardiomyopathy Questionnaire (KCCQ) to detect and quantify symptoms...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2010.08.009

    authors: Shlipak MG,Lash JP,Yang W,Teal V,Keane M,Cappola T,Keller C,Jamerson K,Kusek J,Delafontaine P,He J,Miller ER 3rd,Schreiber M,Go AS,CRIC Investigators.

    更新日期:2011-01-01 00:00:00

  • Restrictive filling pattern is a powerful predictor of heart failure events postacute myocardial infarction and in established heart failure: a literature-based meta-analysis.

    abstract:BACKGROUND:Two recent literature-based meta-analyses revealed that restrictive filling pattern (RFP) was associated with a 4-fold increase in the risk of death in patients with heart failure (HF) and postacute myocardial infarction (AMI). This similar but unique analysis evaluated the link between RFP and morbidity. M...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章,meta分析

    doi:10.1016/j.cardfail.2007.01.010

    authors: Somaratne JB,Whalley GA,Gamble GD,Doughty RN

    更新日期:2007-06-01 00:00:00

  • Assessment of left ventricular systolic function by the chest x-ray: comparison with radionuclide ventriculography.

    abstract:BACKGROUND:The value of the plain chest roentgenogram in predicting cardiac status remains controversial. METHODS AND RESULTS:A total of 111 randomly selected survivors of acute myocardial infarction (age 38 to 83 years) were studied prospectively. X-ray and radionuclide examinations were performed on a morning in the...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2004.10.004

    authors: Høilund-Carlsen PF,Gadsbøll N,Hein E,Stage P,Badsberg JH,Jensen BH

    更新日期:2005-05-01 00:00:00

  • Quality of life assessment for acute heart failure patients from emergency department presentation through 30 days after discharge: a pilot study with the Kansas City Cardiomyopathy Questionnaire.

    abstract:BACKGROUND:There are no well validated patient-reported disease status instruments for acute heart failure (HF). We assessed the feasibility of using the Kansas City Cardiomyopathy Questionnaire (KCCQ) during acute heart failure hospitalization, and the association of acute changes with 30-day readmission. METHODS AND...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2013.11.010

    authors: Sauser K,Spertus JA,Pierchala L,Davis E,Pang PS

    更新日期:2014-01-01 00:00:00

  • Quality assurance and cardiopulmonary exercise testing in clinical trials.

    abstract:BACKGROUND:Peak oxygen uptake (VO2) measured during cardiopulmonary exercise testing (CPX) is often used as an outcome measure in clinical trials. The purposes of this study are (a) to report the outcomes of a quality assurance (QA) procedure instituted in multisite clinical trials by a CPX data core laboratory and (b)...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2008.01.001

    authors: Brawner CA,Ehrman JK,Aldred H,Schairer JR,Keteyian SJ

    更新日期:2008-05-01 00:00:00

  • A systematic meta-analysis of the efficacy and heterogeneity of disease management programs in congestive heart failure.

    abstract:BACKGROUND:We sought to systematically combine the evidence on efficacy of disease management programs (DMPs) in the treatment of congestive heart failure (CHF), to identify and explain heterogeneity of results from prior studies of DMPs, and to assess potential publication bias from these studies. METHODS AND RESULTS...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章,meta分析,评审

    doi:10.1016/j.cardfail.2006.03.003

    authors: Göhler A,Januzzi JL,Worrell SS,Osterziel KJ,Gazelle GS,Dietz R,Siebert U

    更新日期:2006-09-01 00:00:00

  • Age, but not sex, influences the measurement of ejection fraction in elderly patients hospitalized for heart failure.

    abstract:BACKGROUND:Current US and European guidelines recommend that ejection fraction (EF) be measured at least once in patients with congestive heart failure (CHF). However, it is not known how age and sex influence adherence to this recommendation. METHODS:We reviewed a national sample of Medicare patients discharged with ...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1054/jcaf.2003.16

    authors: Lindenfeld J,Fiske KS,Stevens BR,Debuhr J,Havranek EP,Abrams FR

    更新日期:2003-04-01 00:00:00

  • Multiple neurohumoral modulating agents in systolic dysfunction heart failure: are we lowering blood pressure too much?

    abstract:BACKGROUND:Disease-modifying drug treatment in heart failure (HF) reduces blood pressure. Titration of these agents is guided by clinic blood pressure readings; however, the impact of such treatment on blood pressure is unknown because diurnal blood pressure patterns remain poorly described. The aim of this study was t...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2008.03.003

    authors: Mak G,Murphy NF,Ali A,Walsh A,O'Loughlin C,Conlon C,McCaffrey D,Ledwidge M,McDonald K

    更新日期:2008-09-01 00:00:00

  • The relationship between leptin and ventilatory control in heart failure.

    abstract:BACKGROUND:Increased serum leptin concentration has been linked to increased ventilation in patients with mild heart failure (HF). However, in animal models the absence of leptin has also been associated with increased ventilation. This study evaluated the relationship of circulating leptin concentration with exercise ...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2013.10.004

    authors: Cundrle I Jr,Somers VK,Singh P,Johnson BD,Scott CG,Olson LJ

    更新日期:2013-11-01 00:00:00

  • Medium-term effects of beta-blockade on left ventricular mechanics: a double-blind, placebo-controlled comparison of nebivolol and atenolol in patients with ischemic left ventricular dysfunction.

    abstract::The aim of this study was to compare the effects on left ventricular function and exercise tolerance of a selective beta-antagonist (atenolol) with those of another selective beta 1-antagonist with vasodilator properties (nebivolol) in patients with ischemic left ventricular dysfunction but no overt congestive heart f...

    journal_title:Journal of cardiac failure

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/s1071-9164(96)80004-2

    authors: Rousseau MF,Chapelle F,Van Eyll C,Stoleru L,Hager D,Van Nueten L,Pouleur H

    更新日期:1996-03-01 00:00:00

  • The Warfarin and Antiplatelet Therapy in Heart Failure trial (WATCH): rationale, design, and baseline patient characteristics.

    abstract:BACKGROUND:The role of anticoagulation in patients with chronic heart failure has long been an area of interest and controversy. Traditionally the goal of anticoagulation has been to prevent embolic events, but recent trials also demonstrated that oral anticoagulation also prevents vascular events in patients with prio...

    journal_title:Journal of cardiac failure

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1016/j.cardfail.2004.02.006

    authors: Massie BM,Krol WF,Ammon SE,Armstrong PW,Cleland JG,Collins JF,Ezekowitz M,Jafri SM,O'Connor CM,Packer M,Schulman KA,Teo K,Warren S

    更新日期:2004-04-01 00:00:00

  • Anger proneness, gender, and the risk of heart failure.

    abstract:BACKGROUND:Evidence regarding the association of anger proneness with incidence of heart failure is lacking. METHODS AND RESULTS:Anger proneness was ascertained among 13,171 black and white participants of the Atherosclerosis Risk in Communities (ARIC) study cohort with the use of the Spielberger Trait Anger Scale. In...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2014.09.010

    authors: Kucharska-Newton AM,Williams JE,Chang PP,Stearns SC,Sueta CA,Blecker SB,Mosley TH

    更新日期:2014-12-01 00:00:00

  • Characteristics of patients who die with heart failure and a low ejection fraction in the new millennium.

    abstract:BACKGROUND:Therapies for heart failure (HF) with a low ejection fraction (EF) have delayed disease progression and prolonged survival, but the implications of these therapies on the end stages of HF have not been examined. METHODS AND RESULTS:Patients seen by the Brigham and Women's cardiomyopathy service with an EF <...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2005.08.001

    authors: Teuteberg JJ,Lewis EF,Nohria A,Tsang SW,Fang JC,Givertz MM,Jarcho JA,Mudge GH,Baughman KL,Stevenson LW

    更新日期:2006-02-01 00:00:00

  • Inotropes and beta-blockers: is there a need for new guidelines?

    abstract::Beta-adrenergic blocking agents are standard treatment for patients with mild-to-moderate heart failure. When patients receiving beta-blockers decompensate they often need treatment with a positive inotropic agent. The beta-agonist dobutamine may not produce much increase in cardiac output during full-dose beta-blocke...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章,评审

    doi:10.1054/jcaf.2001.26655

    authors: Bristow MR,Shakar SF,Linseman JV,Lowes BD

    更新日期:2001-06-01 00:00:00

  • Influence of Donor Transmitted and Rapidly Progressive Coronary Vascular Disease on Long-Term Outcomes After Heart Transplantation: A Contemporary Intravascular Ultrasound Analysis.

    abstract:BACKGROUND:Donor-transmitted atherosclerosis (DTA) and rapidly progressive cardiac allograft vasculopathy (CAV) at 1 year are intravascular ultrasound (IVUS)-derived measures shown to predict adverse cardiovascular outcomes in the setting of early generation immunosuppressive agents. Given the paucity of data on the pr...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2020.12.012

    authors: Sperry BW,Qarajeh R,Omer MA,Brandt H,Safley D,Borkon AM,Everley MP,Fendler TJ,Khumri TM,Lawhorn SL,Magalski A,Nassif ME,Vodnala D,Kao AC,Austin BA

    更新日期:2021-01-20 00:00:00